OneMedRadio interviewed Thomas Braun, CEO of Verisante Technologies [CVE:VRS], a medical device company committed to commercializing innovative systems for the early detection of cancer.
Author: Global Cancer Consortium
Biocept, Inc., a privately-held CLIA-certified laboratory testing company, and Clarient, Inc. (a GE Healthcare Company) say that they will be collaborating on the commercialization of a proprietary blood test for circulating tumor cells…
The directors of ImmunoCellular Therapeutics (OTCBB: IMUC), International Stem Cell (OTCBB: ISCO) and OncoSec Medical Incorporated (OTCBB: ONCS) will be presenting.
Mel Engle, CEO of ThermoGenesis [NASDAQ: KOOL] recently discussed with OneMedRadio, the company’s stem cell products and FDA approval that may have groundbreaking implications for the stem cell market.
Frank Reynolds, President and CEO of InVivo Therapeutics describes the company’s strategy in bringing its unique spinal cord injury (SPI) products to market.
Novadaq Technologies (TSX:NDQ) President & CEO Arun Menawat, Ph.D was interviewed by OneMedRadio and discusses the roll out of his surgical imaging technology.
E-Therapeutics (LON:ETX) expects to generate a “wealth of data” from a clinical programme focusing on four drug candidates.
Inovio Pharmaceuticals reported Friday the positive long-term effects of its VGX-3100 vaccine, designed to treat cervical dysplasia and cancer caused by the human papillomavirus, or HPV.